Head-to-head · WeighScore
Lighter You vs MadeMed
The verdict
MadeMed takes it — 80.4/100 to 74.3/100.
MadeMed grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Publishes its price at every single dose, so what a titrated dose costs is knowable on day one.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Lighter You | MadeMed |
|---|---|---|
| WeighScore | 74.3/100 | 80.4/100 |
| Grade | C | B− |
| Site position | #69 | #23 |
| Semaglutide | $169 per 4 weeks (store and intake price; thirteen charges a year) | $239/mo quarterly (from $199/mo on 6 months) |
| Tirzepatide | $339 per 4 weeks (store and intake price; the marketing site advertises $169) | $399/mo quarterly (from $369/mo on 6 months) |
| Coverage | All 50 states plus Washington, D.C. (claimed; the footer says otherwise) | 40 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Yes | Yes |
Site position #69 · C
Strengths
- The store and the intake agree with each other, so a reader who starts at the store sees the figure that will be charged
- Names four dispensing pharmacies with addresses and phone numbers
- Runs oral, microdose and injectable GLP-1 lines plus a separate peptide sub-brand, so the menu is unusually wide for the price band
- Unlimited video visits and dietitian check-ins are described as included in every plan
- A full refund is offered if a clinician declines the prescription
Where it loses points
- Tirzepatide is advertised at $169 a month on the marketing site and sold at $339 per four weeks in the store and the intake
- The marketing site says “/mo” and the store bills per four weeks, which is thirteen charges a year rather than twelve
- GLP-1 tablets are advertised at $249 and sold at $279 per four weeks; microdosing is advertised at $96 and sold at $179
- The peptide sub-brand prices the same products differently again — NAD+ at $199 against $229, sermorelin at $175 against $229
- The Terms claim all 50 states plus Washington, D.C. and the footer on the same site says not available in all 50 states
- No clinician, medical group or NPI is named, and no compounding class appears anywhere on the domain
- A dietitian visit is promised on the homepage with an asterisk that resolves to no footnote, and neither the Terms nor the refund policy promises one
Site position #23 · B−
Strengths
- One flat price at every dose, published dose by dose — semaglutide 0.25–2.4mg, tirzepatide 2.5–15mg
- LegitScript verified, with board-certified physician review and US compounding pharmacies
- Full refund minus a $39 visit fee if you are not prescribed, stated before checkout
- Oral semaglutide and oral tirzepatide alongside the injections; free overnight shipping with supplies
Where it loses points
- The most expensive tirzepatide here at $399/mo quarterly
- 40 states rather than nationwide
- No published recurring lab program
- Ships one vial every two months, a less flexible cadence than a monthly refill
Featured provider
MadeMed
MadeMed scores 80.4/100 (B−). Publishes its price at every single dose, so what a titrated dose costs is knowable on day one.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.